SBL
CMD

Sargent Bickham Lagudis’s Cantel Medical Corporation CMD Stock Holding History

Sargent Bickham Lagudis’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-75
Closed -$3K – 841
2020
Q1 		$3K Buy
+75
New +$4.26K ﹤0.01% 694

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sargent Bickham Lagudis's CMD Position: Q2 2020 in Review

Sargent Bickham Lagudis sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 75 shares — an estimated $3K sold.

Sargent Bickham Lagudis first reported a position in CMD in Q1 2020 and held it in 1 quarter. The position peaked at $3K in Q1 2020. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Sargent Bickham Lagudis reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 75 Cantel Medical Corporation shares in Q2 2020, an estimated $3K.
  • Sargent Bickham Lagudis first reported a position in Cantel Medical Corporation in Q1 2020 and held it in 1 quarter.
  • Sargent Bickham Lagudis's Cantel Medical Corporation position peaked at $3K in Q1 2020.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Sargent Bickham Lagudis's 13F filing for Q2 2020, filed 7 Sep 2021.